TheGreeks

Key regulator that induces cancer-killing capacity in T cells under hypoxia is identified


Immune checkpoint blockades, or ICBs, have revolutionized treatment for various advanced cancers. However, their effectiveness has plateaued due to therapeutic resistance that renders tumor-infiltrating lymphocytes, or TILs, ineffective. Thus, finding ways to disarm that resistance and rejuvenate anti-cancer TILs so they can kill tumor cells is an important goal for cancer clinicians.


Source link

ibm1
Author: ibm1

Sign up for new Events & Classifieds in your inbox.
Advertise & promotion space
Medusa Sculpture Candles
Medusa Sculpture Candles
These are affiliate links. Clicking these links will transfer you to Amazon website.

You can become an author at TheGREEKS!
For anyone with good writing skills and an interest in going public with their work, we call for submissions

The post should be original and ideally offer something positive to any reader.
Posts must be decent and not insulting to other people: race-color-religion-gender or against a specific individual